Concepedia

Lucy Knight

LK

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2006

Affiliations

AstraZeneca (United Kingdom)(Current)

Cancer Research UK Manchester Institute

The Christie Hospital

The Christie NHS Foundation Trust

Lucy Knight is an author at AstraZeneca (United Kingdom) specializing in oncology, molecular oncology, and medicine.

Publications per year

2006–2020

6

Publications

6

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn et al. · Journal of Clinical Oncology · 2006 · 703 citations · Full text

, , +17

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

Gillian Ellison, Emma Donald, Gael McWalter et al. · Journal of Experimental & Clinical Cancer Research · 2010 · 153 citations · Full text

, , +17

Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer

Victoria Williams, Lucy Knight, Alastair Greystoke et al. · Annals of the New York Academy of Sciences · 2008 · 103 citations

, , +8

DNA methylation in circulating tumour DNA as a biomarker for cancer.

Lucy Knight, Alastair Greystoke, Fiona Blackhall et al. · PubMed · 2008 · 70 citations · Full text

, , +17

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

Lucy Knight, Alastair Greystoke, Fiona Blackhall et al. · Biomarker Insights · 2007 · 52 citations · Full text

, , +17

1–5 of 6